documents: FDA-2024-D-2033-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-D-2033-0001 | FDA | FDA-2024-D-2033 | Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2024-12-06T05:00:00Z | 2024 | 12 | 2024-12-06T05:00:00Z | 2025-06-08T00:55:36Z | 2024-28392 | 0 | 0 | 090000648684b49a |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref